Nikhil Kamath contributes $2.7 million to the longevity firm Biopeak

Longevity Startup Biopeak Raises $2.7 Million from Nikhil Kamath’s NKSquared

Bengaluru: Longevity and preventive healthcare startup Biopeak has raised $2.7 million in a follow-on funding round led by NKSquared, the investment firm of Zerodha cofounder Nikhil Kamath.

This marks Kamath’s second investment in the company, after he invested $1.43 million in August 2024.

Founded in 2025 by Rishi Pardal and Shiva Subramanian, Biopeak operates what it calls India’s first specialised longevity-focused clinic, aimed at extending lifespans through preventive and personalised healthcare. The company opened its first clinic in Bengaluru last year and plans to launch a second clinic next month.

The fresh funds will be used to expand operations, support the new clinic, and strengthen Biopeak’s diagnostics, artificial intelligence tools, research initiatives, and clinical programmes. The startup also plans to hire across clinical, research, product, and operations teams and deepen collaborations with global medical advisors.

Biopeak had earlier raised $3 million in seed funding from Claypond Capital, Accel India cofounder Prashanth Prakash, and Rainmatter, Zerodha’s investment arm.

“Since our last fundraise, we have proven that we can attract clients and deliver outcomes,” said Pardal. “We are building capabilities in advanced diagnostics and AI-driven diagnosis to create personalised health programmes, which require further investment to scale.”

The startup targets high achievers, corporate executives, and women, offering programmes that combine advanced diagnostic tests, wearable data, specialist consultations, and AI-based insights tailored to Indian health patterns.

Its model focuses on early risk detection, continuous health tracking, and preventive interventions to improve long-term performance and resilience.

With rising incomes and growing awareness around preventive healthcare, India’s longevity sector is gaining traction. As life expectancy increases but healthy life years remain limited, startups like Biopeak are tapping into the growing demand for proactive health management.